Metallodrugs are unique: Opportunities and challenges of discovery and development

EJ Anthony, EM Bolitho, HE Bridgewater… - Chemical …, 2020 - pubs.rsc.org
Metals play vital roles in nutrients and medicines and provide chemical functionalities that
are not accessible to purely organic compounds. At least 10 metals are essential for human …

Drug combination in cancer treatment—From cocktails to conjugated combinations

Y Gilad, G Gellerman, DM Lonard, BW O'malley - Cancers, 2021 - mdpi.com
Simple Summary Chemotherapy is a key modality in today's practice of clinical oncology.
The potential for systemic treatment of cancer patients with cytotoxic agents was discovered …

[HTML][HTML] Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma

T Zhang, B Sun, C Zhong, K Xu, Z Wang… - … lung cancer research, 2021 - ncbi.nlm.nih.gov
Background Intrinsic or acquired resistance to epidermal growth factor receptor-tyrosine
kinase inhibitors (EGFR-TKIs) is common, thus strategies for the management of EGFR-TKIs …

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma

H Yang, D Xu, RA Schmid… - Therapeutic advances in …, 2020 - journals.sagepub.com
Malignant pleural mesothelioma (MPM) is a lethal thoracic malignancy whose incidence is
still increasing worldwide. MPM is characterized by frequent inactivation of tumor …

Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell …

H Yang, B Sun, K Xu, Y He, T Zhang, SRR Hall… - …, 2021 - thelancet.com
Background Histone acetylation/deacetylase process is one of the most studied epigenetic
modifications. Histone deacetylase inhibitors (HDACis) have shown clinical benefits in …

Pharmacotranscriptomic analysis reveals novel drugs and gene networks regulating ferroptosis in cancer

H Yang, L Zhao, Y Gao, F Yao, TM Marti, RA Schmid… - Cancers, 2020 - mdpi.com
Simple Summary Ferroptosis is increasingly recognized as a promising avenue for cancer
therapy, while the biomarkers that predict the sensitivity and/or resistance of ferroptosis and …

MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma

H Yang, Y Gao, D Xu, K Xu, SQ Liang, Z Yang… - Cell death …, 2023 - nature.com
Malignant pleural mesothelioma (MPM) is a lethal malignancy etiologically caused by
asbestos exposure, for which there are few effective treatment options. Although asbestos …

Genomics and functional genomics of malignant pleural mesothelioma

E Cakiroglu, S Senturk - International Journal of Molecular Sciences, 2020 - mdpi.com
Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer of the mesothelial cells
lining the pleural surface of the chest wall and lung. The etiology of MPM is strongly …

Ropivacaine inhibits the growth, migration and invasion of gastric cancer through attenuation of WEE1 and PI3K/AKT signaling via miR-520a-3p

N Zhang, X Xing, F Gu, G Zhou, X Liu… - OncoTargets and …, 2020 - Taylor & Francis
Background Metastasis remains one of the greatest challenges involved in treating gastric
cancer (GC). Ropivacaine (Rop) is not only a well-documented local anesthetic medicament …

Organoids as a model for precision medicine in malignant pleural mesothelioma: where are we today?

Y Gao, M Kruithof-de Julio, RW Peng, P Dorn - Cancers, 2022 - mdpi.com
Simple Summary Malignant pleural mesothelioma (MPM) is an extremely lethal cancer,
notoriously known for its limited treatment options, lack of targeted therapies, and …